Nicotine vaccine under development

Jun 26, 2006
Smoking

U.S. scientists say new medications might soon be available to help people stop smoking by attacking nicotine addition in the brain.

Patients in a clinical trial at Massachusetts General Hospital last week received their first doses of an experimental vaccine that keeps most nicotine from entering the brain, The Boston Globe reported.

By late summer, Pfizer Inc. said it expects to begin selling a medication that partially blocks a receptor that seems to be involved in smoking addiction. Another drug under development might "dampen" areas of the brain involved in craving, thus helping smokers quit without gaining much weight, The Globe said.

"For the first time in 10 years, we have completely new approaches for smoking cessation, and there is hope that the new drugs, because they better target the brain's addiction response, could prove more effective than current treatments," said Dr. Nancy Rigotti, director of the hospital's Tobacco Research and Treatment Center.

The National Institutes of Health says of the 44 million Americans who smoke, about 70 percent want to quit and 40 percent really try. But in a given year, fewer than 5 percent of would-be quitters succeed in kicking the habit.

Copyright 2006 by United Press International

Explore further: Recorded Ebola deaths top 7,000

add to favorites email to friend print save as pdf

Related Stories

Study documents cigarette environmental hazards

Sep 06, 2013

Back in the bad old days when teenagers smoked cigarettes to be cool, it wasn't unusual for a teenage girl to surreptitiously pocket a cigarette butt left behind by a boy she had a crush on.

Recommended for you

Recorded Ebola deaths top 7,000

10 hours ago

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

14 hours ago

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

FDA OKs Cubist antibiotic for serious infections

14 hours ago

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.